酸抗凝剂溶液对重症儿童持续静脉血过的作用
Xinyu Ye1,2, Shuai Zhang3,4, Maoting Tang5,6
1Department of Pediatric Intensive Care Unit Nursing, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
BMC pediatrics
|July 2, 2025
概括
酸在重症儿童的持续静脉静脉血过 (CVVH) 期间显示出抗凝剂的卓越安全性和有效性. 与其他抗凝固剂相比,它减少了治疗中断和出血风险.
科学领域:
- 儿科重症监护医学 儿科重症监护医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 持续静脉静脉血过 (CVVH) 是重症儿童的重要置换疗法.
- 有效的抗凝剂对于CVVH电路通透性和患者安全至关重要.
- 常见的抗凝剂包括未分离的肝素,低分子量肝素和酸盐.
研究的目的:
- 为了比较酸,低分子量肝素和非肝素抗凝剂在患有CVVH的重症儿童中的临床抗凝作用.
- 在这个患者群体中评估不同抗凝策略的安全性和有效性.
主要方法:
- 对接受CVVH治疗的86名重症儿童进行了回顾性研究.
- 根据凝血试验结果和使用的抗凝剂,患者被分为几组:低分子量肝素 (a1组),4%酸盐 (a2组) 和非肝素抗凝剂 (b1组).
- 组间凝血参数,治疗中断和不良事件的比较.
主要成果:
- 与肝素/非肝素组 (a1, b1) 相比,酸盐组 (a2, b2) 由于凝血而导致治疗中断的发生率较低.
- 与a1组相比,a2组表现出治疗持续时间的改善,电路凝血的减少和出血风险的降低.
- 没有观察到血液气体,电解质水平,高血,低血或酸平衡的显著差异.
结论:
- 酸是一种更安全,更有效的抗凝血剂,用于CVVH在重症儿童.
- 它在电路通透性和出血风险方面比低分子量肝素和非肝素抗凝剂具有优势.
- 酸盐管理需要对潜在的电解质干扰进行仔细监测,尽管这项研究没有发现显著差异.
更多相关视频
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
8.9K
09:09Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
1.1K
相关概念视频
01:30Continuous Renal Replacement Therapy
156
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
156
01:20Acute Kidney Injury V: Interprofessional Care
49
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
49
01:24Hemodialysis II: Procedure and Complications
146
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
146
01:25Hemodialysis III: Nursing Management
196
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
196
01:25Hemodialysis I: Introduction
310
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
310
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
921
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
921